Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]
News [4199]
Articles [376]
Editorials [10]
Conferences [104]
elearning [29]
Lurbinectedin in PARP resistant breast cancer
Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in PARP resistant breast cancer ( Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Lurbinectedin in BRCA 1/2 breast cancer
Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in BRCA 1/2 breast cancer ( Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Comment: Ribociclib for breast cancer
Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ribociclib for breast cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate
Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate ( Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA )
10 Oct 2016
Highlights of ESMO 2016
Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016
FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer
Prof John Robertson - University of Nottingham, Nottingham, UK
FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer ( Prof John Robertson - University of Nottingham, Nottingham, UK )
8 Oct 2016
Fulvestrant in FALCON trial improves PFS in advanced breast cancer
Dr Matthew Ellis - Washington University in St Louis, USA
Fulvestrant in FALCON trial improves PFS in advanced breast cancer ( Dr Matthew Ellis - Washington University in St Louis, USA )
8 Oct 2016
Ribociclib improves progression-free survival in advanced breast cancer
Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center...
Ribociclib improves progression-free survival in advanced breast cancer ( Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center, Houston, US )
8 Oct 2016
Ribociclib improves PFS for postmenopausal women with hormone receptor-positive...
Dr Gabriel Hortobagyi - MD Anderson, Houston, USA
Ribociclib improves PFS for postmenopausal women with hormone receptor-positive breast cancer ( Dr Gabriel Hortobagyi - MD Anderson, Houston, USA )
8 Oct 2016
Editor's Choice for September 2016
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for September 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )
3 Oct 2016
A rationale for early intervention in ER＋ metastatic breast cancer
Dr Hope Rugo - University of San Francisco Cancer Research Institute, San...
A rationale for early intervention in ER＋ metastatic breast cancer ( Dr Hope Rugo - University of San Francisco Cancer Research Institute, San Francisco, USA )
1 Sep 2016
Patient advocacy in breast cancer research
Maired Mackenzie - Independent Cancer Patients' Voice, UK
Patient advocacy in breast cancer research ( Maired Mackenzie - Independent Cancer Patients' Voice, UK )
4 Aug 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation